SEC Form 3 · accession 0001104659-18-025835
IMMUNOMEDICS INC · IMMU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Usama Malik
Officer — See Remarks
Period of report
Apr 12, 2018
Accepted (ET)
Apr 23, 2018 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.01 per share | holding | — | — | — | 5,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock options (right to buy)F1 | $8.46 | holding | — | — | — | — | Aug 7, 2024 | Common Stock, par value $0.01 per share | 65,000 | — | D |
| Stock options (right to buy)F1 | $16.94 | holding | — | — | — | — | Mar 13, 2025 | Common Stock, par value $0.01 per share | 35,000 | — | D |
| Restricted Stock UnitsF2 | — | holding | — | — | — | — | — | Common Stock, par value $0.01 per share | 20,000 | — | D |
Explanation of responses
- F1The Reporting Person was granted stock options pursuant to the Company's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant and 2.08333% on a monthly basis thereafter.
- F2Each restricted stock unit represents a contingent right to receive one share of Immunomedics, Inc. common stock. The restricted stock units shall vest upon the Reporting Person's completion of one year of service as an employee from the date of grant.
Remarks
Mr. Malik is the Issuer's Chief Business Officer. The Issuer's Board of Directors identified the Mr. Malik as a Section 16 Reporting Officer on April 12, 2018.